eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | essential thrombocythemia |
| Symptom | C0040053|thrombosis |
| Sentences | 21 |
| PubMedID- 19582452 | Evidence suggests that the jak2 v617f mutation is associated with an increased risk of first thrombosis in patients with essential thrombocythemia (et). |
| PubMedID- 24709317 | Deep vein thrombosis occurs in 30% of patients with essential thrombocythemia, but rarely at initial diagnosis. |
| PubMedID- 21287350 | Established risk factors for thrombosis in essential thrombocythemia (et) include age (>/= 60 years) and previous vascular events. |
| PubMedID- 23577924 | Cytoreduction plus low-dose aspirin versus cytoreduction alone as primary prophylaxis of thrombosis in patients with high-risk essential thrombocythaemia: an observational study. |
| PubMedID- 25223529 | The importance of cardiovascular risk factors for thrombosis prediction in patients with essential thrombocythemia. |
| PubMedID- 20623009 | This drug is often used to supplement phlebotomy for patients with polycythemia vera (pv; . |
| PubMedID- 25269924 | Acute myocardial infarction and sub-acute stent thrombosis associated with occult essential thrombocythemia. |
| PubMedID- 21062242 | Hemorrhage, thrombosis and leukemic transformation) of polycythemia vera (pv), essential thrombocythemia (et), and primary myelofibrosis (pmf), the advent of molecular biology has provided substantial molecular insight into the pathobiology of myeloproliferative neoplasia (mpn). |
| PubMedID- 21142409 | This case describes the medical history of a 61-year-old woman treated for cerebral venous thrombosis (cvt) leading to diagnosis of essential thrombocythemia (et). |
| PubMedID- 21490340 | The current study clarifies the contribution of specific disease and host characteristics to the risk of arterial versus venous thrombosis in essential thrombocythemia. |
| PubMedID- 22537896 | Aortic thrombosis in a patient with essential thrombocythemia. |
| PubMedID- 25872987 | New and treatment-relevant risk stratification for thrombosis in essential thrombocythemia and polycythemia vera. |
| PubMedID- 23033268 | Accurate prediction of thrombosis in essential thrombocythemia (et) provides the platform for prospective studies exploring preventive measures. |
| PubMedID- 25997869 | The impact of jak2v617f mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis. |
| PubMedID- 24889737 | Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history. |
| PubMedID- 22446615 | We report a 13-year-old girl who presented with isolated cerebral venous thrombosis and was diagnosed with essential thrombocythemia. |
| PubMedID- 24617727 | Decanucleotide insertion polymorphism of f7 significantly influences the risk of thrombosis in patients with essential thrombocythemia. |
| PubMedID- 22781379 | Very late coronary drug-eluting stent thrombosis in a patient with essential thrombocythemia: a case report of a rare association. |
| PubMedID- 20074024 | Successful pregnancy in a patient with portal hypertension secondary to portal vein thrombosis due to essential thrombocythaemia: a rare case. |
| PubMedID- 20483636 | The development of bone marrow fibrosis and thrombosis are main causes of morbidity in essential thrombocythemia (et). |
| PubMedID- 25170413 | The risk of thrombosis is high in patients with essential thrombocythemia. |
Page: 1